HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Accumulated Expenses of $197.6 million for Q2 2026, down 10.6% year-over-year from $221.1 million in Q2 2025, and up 635.81% quarter-over-quarter from $26.9 million in Q4 2025.
HUTCHMED (China) (HCM) Accumulated Expenses (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Accumulated Expenses for 12 consecutive years, with $197.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accumulated Expenses fell 10.6% year-over-year to $197.6 million; the TTM figure through Jun 2026 stood at $197.6 million (down 10.6% YoY), while the FY2025 annual figure was $26.9 million, down 18.18% from the prior year.
- Accumulated Expenses climbed to $197.6 million in Q2 2026 per HCM's latest filing, from $26.9 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $34.7 billion in Q4 2023 and bottomed at $26.9 million in Q4 2025.
- Historically, Accumulated Expenses has averaged $4.0 billion across 5 years, with a median of $221.1 million in 2025.
- Annual changes were most pronounced in 2023 — Accumulated Expenses surged 102575.61% — and 2024, when it slumped 99.91%.
- HUTCHMED (China)'s Accumulated Expenses stood at $33.8 million in 2022, then soared by 102575.61% to $34.7 billion in 2023, then plunged by 99.91% to $32.9 million in 2024, then decreased by 18.48% to $26.9 million in 2025, then soared by 635.81% to $197.6 million in 2026.
- Business Quant data shows HCM's Accumulated Expenses at $197.6 million in Q2 2026, $26.9 million in Q4 2025, and $221.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 197.63 Mn |
| Dec 31, 2025 | 26.86 Mn |
| Jun 30, 2025 | 221.06 Mn |
| Dec 31, 2024 | 32.95 Mn |
| Jun 30, 2024 | 249.22 Mn |
| Dec 31, 2023 | 34.73 Bn |
| Jun 30, 2023 | 227.21 Mn |
| Dec 31, 2022 | 33.83 Mn |
| Jun 30, 2022 | 233.61 Mn |
| Dec 31, 2021 | 27.07 Mn |
| Jun 30, 2021 | 181.61 Mn |
| Mar 31, 2021 | 150.33 Mn |
| Jun 30, 2020 | 86.99 Mn |
| Sep 30, 2019 | 74.75 Mn |
| Jun 30, 2019 | 75.57 Mn |
| Mar 31, 2019 | 64.16 Mn |
| Dec 31, 2018 | 56.33 Mn |
| Jun 30, 2018 | 49.67 Mn |
| Dec 31, 2017 | 40.95 Mn |
| Jun 30, 2017 | 27.65 Mn |